SEARCH

SEARCH BY CITATION

References

  • 1
    Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8: 365400.
  • 2
    Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 67387.
  • 3
    Ruoslahti E. Integrins. J Clin Invest 1991; 87: 15.
  • 4
    Ruoslahti E,Noble NA,Kagami S,Border WA. Integrins. Kidney Int Suppl 1994; 44: S17S22.
  • 5
    Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 42534.
  • 6
    Ruoslahti E,Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 4917.
  • 7
    Dransfield I,Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin α subunits. Embo J 1989; 8: 375965.
  • 8
    Fitzgerald LA,Phillips DR. Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem 1985; 260: 1136674.
  • 9
    Fujimura K,Phillips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem 1983; 258: 1024752.
  • 10
    Hynes RO. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol 1996; 180: 40212.
  • 11
    Kirchhofer D,Grzesiak J,Pierschbacher MD. Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J Biol Chem 1991; 266: 44717.
  • 12
    Argraves WS,Suzuki S,Arai H,Thompson K,Pierschbacher MD,Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105: 118390.
  • 13
    Loftus JC,O'Toole TE,Plow EF,Glass A,Frelinger ALIII,Ginsberg MH. A β 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990; 249: 91518.
  • 14
    Binkley CE,Zhang L,Greenson JK,Giordano TJ,Kuick R,Misek D,Hanash S,Logsdon CD,Simeone DM. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas 2004; 29: 25463.
  • 15
    Linder S,Castanos-Velez E,von Rosen A,Biberfeld P. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 2001; 48: 13217.
  • 16
    Mollenhauer J,Roether I,Kern HF. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas 1987; 2: 1424.
  • 17
    Stein WD,Litman T,Fojo T,Bates SE. A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. Cancer Res 2004; 64: 280516.
  • 18
    Armstrong T,Packham G,Murphy LB,Bateman AC,Conti JA,Fine DR,Johnson CD,Benyon RC,Iredale JP. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 2004; 10: 742737.
  • 19
    Bachem MG,Schunemann M,Ramadani M,Siech M,Beger H,Buck A,Zhou S,Schmid-Kotsas A,Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005; 128: 90721.
  • 20
    Grzesiak JJ,Bouvet M. The α2β1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 2006; 94: 131119.
  • 21
    Grzesiak JJ,Smith KC,Chalberg C,Burton DW,Deftos LJ,Bouvet M. Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase, migration, and decrease PTHrP, IL-6, and. IL-8 expression in pancreatic cancer cells. Int J Gastrointest Cancer 2005; 36: 13146.
  • 22
    Imamichi Y,Konig A,Gress T,Menke A. Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene 2007; 26: 23815.
  • 23
    Koenig A,Mueller C,Hasel C,Adler G,Menke A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res 2006; 66: 466271.
  • 24
    Shintani Y,Hollingsworth MA,Wheelock MJ,Johnson KR. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res 2006; 66: 1174553.
  • 25
    Grzesiak JJ,Ho JC,Moossa ARBouvet M. The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 2007; 35: 293301.
  • 26
    Grzesiak JJBouvet M. Determination of the ligand binding specificities of the α2β1 and α1β1 integrins in a novel three-dimensional in vitro model of pancreatic cancer. Pancreas 2007; 34: 2208.
  • 27
    Grzesiak JJ,Davis GE,Kirchhofer D,Pierschbacher MD. Regulation of α 2 β 1-mediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol 1992; 117: 110917.
  • 28
    Grzesiak JJ,Pierschbacher MD. Changes in the concentrations of extracellular Mg++ and Ca++ down-regulate E-cadherin and up-regulate α 2 β 1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol 1995; 104: 76874.
  • 29
    Grzesiak JJ,Pierschbacher MD. Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest 1995; 95: 22733.
  • 30
    Bardeesy N,DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2: 897909.
  • 31
    Menke A,Adler G. TGFβ-induced fibrogenesis of the pancreas. Int J Gastrointest Cancer 2002; 31: 416.
  • 32
    Ishihara N,Yoshida A,Koizumi M. Metal concentrations in human pancreatic juice. Arch Environ Health 1987; 42: 35660.
  • 33
    Shimoyama S,Gansauge F,Gansauge S,Oohara T,Beger HG. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas. Int J Pancreatol 1995; 18: 22734.
  • 34
    Cunningham JJ,Anbar RD,Crawford JD. Hypomagnesemia: a multifactorial complication of treatment of patients with severe burn trauma. JPEN J Parenter Enteral Nutr 1987; 11: 3647.
  • 35
    Durlach J. Magnesium and its relationship to oncology. In: SigelH,SigelA, eds.Metal ions in biological systems, vol. 26. New York: Marcel Dekker, 1990. 54978.
  • 36
    Durlach J,Bara M,Guiet-Bara A,Collery P. Relationship between magnesium, cancer and carcinogenic or anticancer metals. Anticancer Res 1986; 6: 135361.
  • 37
    Grzesiak JJ,Clopton P,Chalberg C,Smith K,Burton DW,Silletti S,Moossa AR,Deftos LJ,Bouvet M. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells. Pancreas 2004; 29: 8592.
  • 38
    Ruoslahti E,Hayman EG,Pierschbacher M,Engvall E. Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 1982; 82(Part A): 80331.
  • 39
    Hoffstrom BG,Wayner EA. Immunohistochemical techniques to study the extracellular matrix and its receptors. Methods Enzymol 1994; 245: 31646.
  • 40
    Wayner EA,Carter WG,Piotrowicz RS,Kunicki TJ. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 1988; 107: 188191.
  • 41
    Grzesiak JJ,Smith KC,Burton DW,Deftos LJ,Bouvet M. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. Int J Cancer 2005; 114: 52230.
  • 42
    Grzesiak JJ,Smith KC,Chalberg C,Truong C,Burton DW,Deftos LJ,Bouvet M. Heat shock protein-70 expressed on the surface of cancer cells binds parathyroid hormone-related protein in vitro. Endocrinology 2005; 146: 356776.
  • 43
    White DJ,Puranen S,Johnson MS,Heino J. The collagen receptor subfamily of the integrins. Int J Biochem Cell Biol 2004; 36: 140510.
  • 44
    Popova SN,Lundgren-Akerlund E,Wiig H,Gullberg D. Physiology and pathology of collagen receptors. Acta Physiol (Oxf) 2007; 190: 17987.
  • 45
    Li X,Ma Z,Zhu J,Li K,Wang S,Bie P,Dong J. Laminin-5 promotes cell motility by regulating the function of the integrin α6β1 in pancreatic cancer. Carcinogenesis 2004; 25: 2283.
  • 46
    Sawai H,Yamamoto M,Okada Y,Sato M,Akamo Y,Takeyama H,Manabe T. Alteration of integrins by interleukin-1α in human pancreatic cancer cells. Pancreas 2001; 23: 399405.
  • 47
    Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 14515.
  • 48
    Iacobuzio-Donahue CA,Ashfaq R,Maitra A,Adsay NV,Shen-Ong GL,Berg K,Hollingsworth MA,Cameron JL,Yeo CJ,Kern SE,Goggins M,Hruban RH. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63: 861422.
  • 49
    Iacobuzio-Donahue CA,Maitra A,Olsen M,Lowe AW,van Heek NT,Rosty C,Walter K,Sato N,Parker A,Ashfaq R,Jaffee E,Ryu B, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003; 162: 115162.
  • 50
    Mirtti T,Nylund C,Lehtonen J,Hiekkanen H,Nissinen L,Kallajoki M,Alanen K,Gullberg D,Heino J. Regulation of prostate cell collagen receptors by malignant transformation. Int J Cancer 2006; 118: 88998.
  • 51
    Thavmilselvan V,Fomby M,Walsh M,Basson MD. Divalent cations modulate human colon cancer cell adhesion. J Surg Res 2003; 110: 25565.
  • 52
    van der Voort van Zyp J,Conway WC,Thamilselvan V,Polin L,Basson MD. Divalent cations influence colon cancer cell adhesion in a murine transplantable tumor model. Am J Surg 2005; 190: 7017.
  • 53
    Nakao A,Fujii T,Sugimoto H,Kanazumi N,Nomoto S,Kodera Y,Inoue S,Takeda S. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12: 446672.
  • 54
    van Grevenstein WM,Hofland LJ,Jeekel J,van Eijck CH. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. Pancreas 2006; 32: 396402.
  • 55
    Bouvet M,Spernyak J,Katz MH,Mazurchuk RV,Takimoto S,Bernacki R,Rustum YM,Moossa AR,Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Res 2005; 65: 982933.
  • 56
    Bouvet M,Tsuji K,Yang M,Jiang P,Moossa AR,Hoffman RM. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 2006; 66: 112937.
  • 57
    Bouvet M,Wang J,Nardin SR,Nassirpour R,Yang M,Baranov E,Jiang P,Moossa AR,Hoffman RM. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 2002; 62: 153440.
  • 58
    Katz MH,Bouvet M,Takimoto S,Spivack D,Moossa AR,Hoffman RM. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res 2004; 64: 182833.
  • 59
    Katz MH,Takimoto S,Spivack D,Moossa AR,Hoffman RM,Bouvet M. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 2003; 113: 15160.
  • 60
    Katz MH,Takimoto S,Spivack D,Moossa AR,Hoffman RM,Bouvet M. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis 2004; 21: 712.